Wenli Yang

Title: Innovations of Wenli Yang in Neurotoxin Research

Introduction

Wenli Yang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of neurotoxin research, particularly through his innovative work on short chain neurotoxins derived from sea snake venom. His research has implications for pain management and therapeutic applications.

Latest Patents

Wenli Yang holds a patent for an invention that involves the identification and modification of three genes encoding short chain neurotoxins. These genes, named sn12, sn36, and sn160, were obtained through the construction of a cDNA library from the venom gland of sea snakes. The genes were amplified using the PCR method and subsequently cloned into the expression vector PETTRX. The resulting neurotoxins were expressed in soluble fusion protein in the BL21-DE3 strain, which was induced with IPTG. Studies demonstrated that the three recombinant short chain neurotoxins significantly increased the pain threshold in mice, showcasing their potential analgesic effects.

Career Highlights

Wenli Yang is affiliated with Zhongshan University, where he conducts his research and development activities. His work has garnered attention for its innovative approach to understanding and utilizing neurotoxins for medical purposes.

Collaborations

Wenli Yang collaborates with notable colleagues, including Anlong Xu and Xiaofen Zhong, who contribute to his research endeavors and enhance the scope of his projects.

Conclusion

Wenli Yang's innovative research on neurotoxins represents a significant advancement in the field of pain management. His contributions not only highlight the potential of natural compounds in therapeutic applications but also pave the way for future research in this area.